SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-20-023272
Filing Date
2020-08-21
Accepted
2020-08-21 16:17:19
Documents
1
Period of Report
2020-08-19

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3804
  Complete submission text file 0001213900-20-023272.txt   5318
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
Kintara Therapeutics, Inc. (Issuer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 12707 HIGH BLUFF DRIVE, SUITE 200 SAN DIEGO CA 92130
Business Address
Liatos John (Reporting) CIK: 0001821508 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37823 | Film No.: 201123588